ArticleWorld journal of microbiology & biotechnology2026
Metabolic adaptations of yeast cells to epigenetic modifiers: a comparative analysis of free amino acid profiles and key metabolites.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epigenetic regulation of metabolism in Saccharomyces cerevisiae: mechanisms, metabolic crosstalk, and engineering applications.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the effects of four epigenetic treatments on the free amino-acid and central-carbon metabolite profiles of Saccharomyces cerevisiae. The objective was to assess how naturally derived epigenetic agents reshape yeast metabolism, with a particular focus on amino-acid pools and key intermediates of glycolysis and the tricarboxylic acid (TCA) cycle. Yeast cultures were grown in media supplemented with 5-azacytidine, sodium butyrate, curcumin, or green tea extract, and metabolites were quantified using LC-MS/MS. All four treatments induced marked shifts in amino-acid abundance. Essential amino acids-including leucine, tryptophan, and phenylalanine-significantly increased, with azacytidine yielding the strongest elevation (up to two-fold relative to control). Non-essential amino acids showed similar upward trends across treatments. Central-carbon metabolites such as pyruvate, acetyl-CoA, and citrate also accumulated substantially. Correlation-based and network analyses revealed coordinated modules linking amino-acid metabolism with energy-producing pathways, and enrichment analysis highlighted perturbations in gluconeogenesis and fatty-acid metabolism. Collectively, these results provide a quantitative and network-level perspective on metabolic reorganization induced by epigenetic modulators and establish a reference framework for future multi-omics investigations in yeast.
Indexed as
Identifiers
41493717What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.